| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
56,238 |
39,621 |
$4.36M |
| 90651 |
|
780 |
652 |
$28K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
24,906 |
19,254 |
$27K |
| 90670 |
|
1,084 |
969 |
$9K |
| 90686 |
|
651 |
602 |
$7K |
| 90633 |
|
1,067 |
942 |
$6K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,863 |
2,313 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,250 |
6,898 |
$6K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,488 |
6,261 |
$5K |
| 90715 |
|
362 |
257 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,525 |
1,289 |
$5K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,490 |
1,269 |
$4K |
| 90677 |
|
197 |
165 |
$4K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,093 |
1,578 |
$3K |
| 87428 |
|
3,095 |
2,689 |
$3K |
| 90734 |
|
293 |
259 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,416 |
3,005 |
$3K |
| 90710 |
|
345 |
304 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,999 |
3,506 |
$2K |
| 90680 |
|
306 |
258 |
$2K |
| 90698 |
|
283 |
276 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
453 |
433 |
$1K |
| 90697 |
|
215 |
142 |
$910.41 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,084 |
3,052 |
$898.24 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,623 |
1,283 |
$748.38 |
| 90696 |
|
189 |
160 |
$701.08 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
336 |
326 |
$575.25 |
| 87634 |
|
161 |
157 |
$556.56 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
108 |
86 |
$550.45 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
543 |
519 |
$538.72 |
| 87807 |
|
1,769 |
1,544 |
$411.44 |
| 90656 |
|
161 |
121 |
$345.15 |
| 92551 |
|
1,966 |
1,758 |
$312.81 |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
2,886 |
2,176 |
$311.31 |
| 90744 |
|
91 |
75 |
$288.88 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
992 |
824 |
$159.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
1,192 |
1,005 |
$125.57 |
| 90649 |
|
16 |
14 |
$112.00 |
| 99173 |
|
2,515 |
2,254 |
$106.05 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,258 |
1,798 |
$99.99 |
| 71046 |
Radiologic examination, chest; 2 views |
42 |
37 |
$99.25 |
| 36415 |
Collection of venous blood by venipuncture |
2,278 |
2,129 |
$67.41 |
| 96127 |
|
460 |
366 |
$47.80 |
| 81025 |
|
2,572 |
2,185 |
$44.20 |
| 81002 |
|
592 |
534 |
$41.76 |
| 81003 |
|
646 |
542 |
$39.10 |
| 99307 |
|
2,244 |
1,856 |
$35.73 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
47 |
28 |
$33.38 |
| 99201 |
|
31 |
25 |
$32.07 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
80 |
67 |
$22.10 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
26 |
25 |
$20.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
276 |
247 |
$19.63 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
94 |
86 |
$15.88 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
50 |
43 |
$11.90 |
| 85018 |
|
165 |
152 |
$7.26 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,112 |
870 |
$6.34 |
| 87210 |
|
56 |
52 |
$4.36 |
| 36416 |
|
79 |
43 |
$3.45 |
| 3078F |
|
2,810 |
1,832 |
$0.00 |
| 1160F |
|
1,742 |
1,353 |
$0.00 |
| 1159F |
|
3,087 |
2,447 |
$0.00 |
| 3077F |
|
1,323 |
803 |
$0.00 |
| 96160 |
|
91 |
88 |
$0.00 |
| 90473 |
|
34 |
30 |
$0.00 |
| 3074F |
|
3,563 |
2,293 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
656 |
448 |
$0.00 |
| 3008F |
|
6,366 |
3,865 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
92 |
53 |
$0.00 |
| 3066F |
|
213 |
145 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
114 |
72 |
$0.00 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
962 |
661 |
$0.00 |
| 4010F |
|
278 |
205 |
$0.00 |
| 3044F |
|
270 |
200 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
53 |
50 |
$0.00 |
| 3061F |
|
160 |
112 |
$0.00 |
| 3075F |
|
277 |
228 |
$0.00 |
| 3079F |
|
475 |
376 |
$0.00 |
| 96161 |
|
16 |
15 |
$0.00 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
37 |
24 |
$0.00 |
| 3080F |
|
174 |
136 |
$0.00 |